Oncotype DX Eligibility Quiz Results
No, you may not be a candidate for the Oncotype DX tests.
The Oncotype DX test is a genomic test that may help guide treatment decisions for patients with non-invasive breast cancer, often referred to as ductal carcinoma in situ (DCIS), and help early-stage invasive breast cancer patients with estrogen receptor-positive (ER+) HER2 negative disease with node negative or up to three positive lymph nodes evaluate if they will benefit from chemotherapy.
If you are a caregiver looking for support or additional information about breast cancer, please consider visiting: www.cancercare.com.
Return to the eligibility start page.
If you would like to speak about the Oncotype DX test with a knowledgeable customer service specialist at Exact Sciences, please call: 855.5000.ASK (855-500-0275).